Boundless Bio BOLD
NASDAQ BOLD
$3.00 +0.10 (+3.45%)
At close: Aug 21, 2026 · 4:00 PM EDT

Boundless Bio (BOLD) EPS (Basic) (2023 - 2026)

Boundless Bio (BOLD) posted quarterly EPS (Basic) of -$3.64 for Q1 2026, down 412.37% year-over-year from $1.17 in Q1 2025, and down 454.71% quarter-over-quarter from -$0.66 in Q4 2025.

Boundless Bio (BOLD) EPS (Basic) (2023 - 2026) Analysis & Trends

Boundless Bio (BOLD) has reported EPS (Basic) for 4 consecutive years, with -$3.64 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) fell 412.37% year-over-year to -$3.64; the TTM figure through Mar 2026 stood at -$9.21 (down 195.03% YoY), while the FY2025 annual figure was -$2.72, up 32.07% from the prior year.
  • EPS (Basic) retreated to -$3.64 in Q1 2026 per BOLD's latest filing, from -$0.66 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.66 in Q4 2025 and bottomed at -$40.0 in Q1 2024.
  • Historically, EPS (Basic) has averaged -$7.37 across 4 years, with a median of -$3.64 in 2026.
  • Annual changes were most pronounced in 2025 — EPS (Basic) jumped 98.22% — and 2026, when it tumbled 412.37%.
  • Boundless Bio's EPS (Basic) stood at -$10.59 in 2023, then jumped by 90.62% to -$0.99 in 2024, then surged by 33.85% to -$0.66 in 2025, then tumbled by 454.71% to -$3.64 in 2026.
  • Business Quant data shows BOLD's EPS (Basic) at -$3.64 in Q1 2026, -$0.66 in Q4 2025, and -$3.82 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 12.62
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 7.59
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.23
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -0.72
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.18
10 Boundless Bio 67.35 Mn 67.35 Mn - -1.06

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.18
Mar 31, 2026 -3.64
Dec 31, 2025 -0.66
Sep 30, 2025 -3.82
Jun 30, 2025 -1.10
Mar 31, 2025 -0.71
Dec 31, 2024 -0.99
Sep 30, 2024 -0.75
Jun 30, 2024 -0.92
Mar 31, 2024 -40.00
Dec 31, 2023 -10.59
Sep 30, 2023 -11.30
Jun 30, 2023 -10.87
Mar 31, 2023 -10.48